According to TechFlame, Silo Pharma, Inc. (NASDAQ: SILO), a diversified development stage biopharmaceutical and cryptocurrency treasury management company, announced the initial purchase of ResearchCoin (RSC) as an important step to expand its digital asset treasury strategy, with the aim of extracting long-term value from emerging multi-chain opportunities. RSC is the native token of the decentralized research collaboration platform ResearchHub, which was co-founded by Coinbase CEO Brian Armstrong in 2019. Eric Weisblom, CEO of Silo Pharma, said: “By deploying RSC, we are not only participating in the growing Decentralized Science (DeSci) movement, but also diversifying our assets and potentially adding value to our shareholders. “The investment in ResearchCoin underscores our focus on modernizing research collaboration and support for blockchain-driven innovation as a pillar of biomedical discovery.”